References
- Danhof M., Krom D. P., Breimer D. D. Studies on the different metabolic pathway of antipyrine in rats: influence of phenobarbital and 3-methy!cholanthrene treatment. Xenobiotica 1979; 9: 695–702
- Dssing M., Poulsen H. E., Andreasen P. B., Tygstrup N. A simple method for determination of antipyrine clearance. Clinical Pharmacology and Therapeutics 1982; 32: 392–396
- Dssing M., Vlund A., Poulsen H. E. Optimal sampling times for minimum variance of clearance determination. British Journal of Clinical Pharmacology 1983; 15: 231–235
- Hansen B. A., Poulsen H. E. The capacity of urea-N synthesis as a quantitative measure of the liver mass in rats. Journal of Hepatology 1986; 2: 468–474
- Higgens G. M., Anderson R. M. Experimental pathology of the liver. Restoration of the liver of the white rat following partial surgical removal. Archives of Pathology 1931; 12: 186–202
- Kahn G. C., Boobis A. R., Murray S., Davies D. S. Differential effects of 3-methylcholanthrene and phenobarbitone treatment on the oxidative metabolism of antipyrinein vitro by microsomal fractions of rat liver. Xenobiotica 1982; 12: 509–516
- Loft S., Nielsen A. J., Borg B. E., Poulsen H. E. Metronidazole and antipyrine metabolism in the rat: clearance determination from one saliva sample. Xenobiotica 1991; 21: 33–46
- Loft S., Poulsen H. E. Metabolism of metronidazole and antipyrine in isolated rat hepatocytes. Influence of sex and enzyme induction and inhibition. Biochemical Pharmacology 1989; 38: 1125–1136
- Loft S., Poulsen H. E., Sonne J., Dssing M. Metronidazole clearance: a one-sample method and influencing factors. Clinical Pharmacology and Therapeutics 1988; 43: 420–428
- Okey A. B. Enzyme induction in the cytochrome P450 system. Pharmaceutical Therapeutics 1990; 45: 241–298
- Oshinsky R. J., Strobel H. W. Drug metabolism in rat colon: resolution of enzymatic constituents and characterization of activity. Molecular and Cellular Biochemistry 1987a; 75: 51–60
- Oshinsky R. J., Strobel H. W. Distributions and properties of cytochromes P-450 and cytochrome P-450 reductase. International Journal of Biochemistry 1987b; 19: 575–588
- Pilsgaard H., Poulsen H. E. A one-sample method for antipyrine clearance determination in rats. Pharmacology 1984; 29: 110–116
- Poulsen H. E. One sample antipyrine clearance after 90% partial hepatectomy in the rat. Liver 1985; 5: 200–204
- Rhodes J. C., Houston J. B. Antipyrine metabolite kinetics in phenobarbital and β-naphthoflavone-induced rats. Drug Metabolism and Disposition 1983; 11: 131–136
- Tamura S., Kawata S., Okamoto M., Tarui S. Localization of cytochrome P-450 in the colonic mucosa of 3-methylcholanthrene-pretreated and untreated rats. Cell and Tissue Research 1988; 252: 397–401
- Welch R. M., De Angelis R. L., Wingfield M., Farmer T. W. Elimination of antipyrine from saliva as a measure of metabolism in man. Clinical Pharmacology and Therapeutics 1975; 18: 249–258